| In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 |
| | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K |
| Revenues: |
| USA | | | | | | | | 23.3 |
| Other | | | | | | | | 16.6 |
| Total revenues [+] | 41.6 | 31.1 | 26.2 | 23.7 | 14.8 | 13.4 | 13.0 | 39.9 |
| Products | | | | | | | 13.0 | 39.9 |
| Net interest income | | | | | | | | -2.6 |
| Revenue growth [+] | 33.7% | 18.8% | 10.5% | 60.6% | 10.5% | 2.9% | -67.5% | -0.5% |
| USA | | | | | | | | 1.1% |
| Cost of goods sold | 42.4 | 30.7 | 28.7 | 24.6 | 11.8 | 9.6 | 9.9 | 31.8 |
| Gross profit | -0.8 | 0.4 | -2.5 | -0.9 | 3.0 | 3.8 | 3.1 | 8.1 |
| Gross margin | -1.8% | 1.4% | -9.4% | -3.6% | 20.2% | 28.4% | 24.1% | 20.2% |
| Selling, general and administrative [+] | 6.7 | 7.1 | 8.0 | 13.7 | 11.2 | 9.9 | 12.4 | 12.6 |
| General and administrative | | | | | | | | 12.6 |
| Other selling, general and administrative | | | | | | | | |
| Research and development | | | | | | | | |
| Other operating expenses | -0.2 | | | | | | | |
| EBITDA [+] | -5.0 | -4.1 | -7.8 | -12.6 | -7.4 | -5.3 | -8.3 | -2.2 |
| EBITDA growth | 23.6% | -48.2% | -38.1% | 69.8% | 39.3% | -35.8% | 276.0% | -64.4% |
| EBITDA margin | -12.0% | -13.0% | -29.9% | -53.3% | -50.4% | -40.0% | -64.1% | -5.5% |
| Depreciation and amortization | 2.1 | 2.4 | 2.4 | 1.9 | 0.7 | 0.8 | 0.9 | 4.1 |
| EBITA | -7.1 | -6.5 | -10.2 | -14.5 | -8.2 | -6.1 | -9.3 | -6.3 |
| EBITA margin | -17.1% | -20.7% | -39.0% | -61.3% | -55.3% | -45.7% | -71.3% | -15.7% |
| Amortization of intangibles | 0.1 | 0.2 | 0.2 | 0.0 | 0.0 | | | |
| EBIT [+] | -7.3 | -6.6 | -10.4 | -14.6 | -8.2 | -6.1 | -9.3 | -6.3 |
| EBIT growth | 9.3% | -36.4% | -28.3% | 77.3% | 34.7% | -34.1% | 47.5% | -50.8% |
| EBIT margin | -17.4% | -21.3% | -39.9% | -61.4% | -55.6% | -45.7% | -71.3% | -15.7% |
| Non-recurring items [+] | 0.0 | 3.9 | 0.8 | 0.0 | | | | |
| Asset impairment | | 3.9 | | | | | | |
| Loss (gain) on sale of assets | -0.1 | 0.0 | 0.8 | | | | | |
| Interest expense, net [+] | 0.6 | 0.5 | 0.3 | 0.0 | 0.0 | 1.6 | 2.5 | 3.0 |
| Interest expense | 0.6 | 0.5 | 0.3 | 0.1 | 0.0 | 1.6 | 2.5 | 3.1 |
| Interest income | 0.0 | 0.0 | 0.0 | 0.1 | | | | 0.1 |
| Other income (expense), net [+] | 0.0 | 2.1 | -0.1 | 0.9 | 0.2 | -7.5 | 3.8 | -1.5 |
| Litigation settlement | | | | | | | 1.6 | |
| Gain (loss) on debt retirement | | 1.8 | | | | -8.3 | | -1.9 |
| Unrealized gain/loss on derivatives | | | | | | 0.7 | 1.6 | 1.0 |
| Gain (loss) on foreign currency transactions | | | | | | | | -0.4 |
| Other non-operating income | 0.0 | 0.0 | 0.0 | 0.9 | 0.2 | 0.3 | 0.6 | |
| Other non-ooperating expenses | -0.2 | -0.1 | -0.1 | 0.0 | 0.0 | -0.2 | | |
| Other | -0.2 | -0.1 | -0.1 | 0.9 | 0.2 | 0.1 | 0.6 | -0.2 |
| Pre-tax income | -7.8 | -8.9 | -11.7 | -13.7 | -8.1 | -15.2 | -8.0 | -10.8 |
| Income taxes | 0.0 | 0.0 | 0.0 | 0.2 | 0.0 | -5.0 | -1.8 | -0.2 |
| Tax rate | | | | | | 33.1% | 22.9% | 1.6% |
| Minority interest | | | | | | | | -2.3 |
| Earnings from continuing ops | -7.9 | -8.9 | -11.7 | -13.7 | -8.1 | -9.3 | -4.0 | -8.3 |
| Earnings from discontinued ops | | | | | | 4.0 | -5.1 | |
| Net income | -7.9 | -8.9 | -11.7 | -14.0 | -8.1 | -5.3 | -9.1 | -8.3 |
| Net margin | -18.9% | -28.7% | -44.8% | -58.8% | -54.9% | -39.8% | -70.0% | -20.7% |
| |
| Basic EPS [+] | ($1.42) | ($1.87) | ($0.29) | ($0.42) | ($0.37) | ($0.78) | ($0.42) | ($0.90) |
| Growth | -24.0% | 557.3% | -32.8% | 15.8% | -53.0% | 83.7% | -52.9% | -77.3% |
| Diluted EPS [+] | ($1.42) | ($1.87) | ($0.29) | ($0.42) | ($0.37) | ($0.78) | ($0.42) | ($0.90) |
| Growth | -24.0% | 557.3% | -32.8% | 15.8% | -53.0% | 83.7% | -52.9% | -77.3% |
| |
| Shares outstanding (basic) [+] | 5.5 | 4.8 | 41.1 | 32.4 | 22.1 | 11.9 | 9.3 | 9.2 |
| Growth | 15.5% | -88.4% | 27.1% | 46.4% | 85.3% | 27.7% | 1.6% | 58.2% |
| Shares outstanding (diluted) [+] | 5.5 | 4.8 | 41.1 | 32.4 | 22.1 | 11.9 | 9.3 | 9.2 |
| Growth | 15.5% | -88.4% | 27.1% | 46.4% | 85.3% | 27.7% | 1.6% | 58.2% |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |